UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Creating a financial plan? Learn what to include to ensure your success and financial stability for the future.
23,717 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
As the 10-year yield fluctuates and inflation data shape policy bets, homeowners and buyers ask how much higher mortg...
Investors are weighing whether AMD can reach $600 this year as AI-driven demand and enterprise partnerships could lif...
Ripple-focused ETFs posted another week of net inflows even as XRP struggled to rally. The divergence highlights a sp...
AMD surged about 5% in early trading, leading a broad chip rally as investors weigh AI infrastructure bets against pe...
Rent prices dropping nationwide are reshaping tenant leverage as supply catches up with demand. This report flags whe...
Vanguard’s FTSE Emerging Markets ETF (VWO) omits South Korea due to a 2009 reclassification, leaving investors expose...
The stock move is sharp, but so is the story behind choice hotels stock down. An investor dumped more than $100 milli...
Mortgage application fraud risk fell 9.3% year over year in Q1 2026, signaling a return to long-run norms as refinanc...
Investors weigh PepsiCo's international rebound and resilient dividends as the stock nears recent highs. The question...
Funds that rode big EM winners are rotating out of maxed TSMC and Samsung Hynix and chasing new catalysts. The shift ...
A sweeping crypto downturn sparks roughly $1.2 billion in liquidations, as Ethereum tests key support under $1.7K and...